Paper42226192
Evolution of treatment and oncological outcomes in patients undergoing radical cystectomy: a comparative analysis across two decades at a tertiary center.
Suartz CV and 11 others. BMC Urol, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Evolution of treatment and oncological outcomes in patients undergoing radical cystectomy: a comparative analysis across two decades at a tertiary center. Papers, record 42226192. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42226192
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Evolution of treatment and oncological outcomes in patients undergoing radical cystectomy: a comparative analysis across two decades at a tertiary center.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cystectomy | Major topic |
| Urinary Bladder Neoplasms | Major topic |
| Humans | |
| Male | |
| Female | |
| Retrospective Studies | |
| Aged | |
| Treatment Outcome | |
| Tertiary Care Centers | |
| Middle Aged | |
| Time Factors |
Source PubMed
References22
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34023169 | Robot assisted radical cystectomy with Florence robotic intracorporeal neobladder (FloRIN): Analysis of survival and functional outcomes after first 100 consecutive patients upon accomplishment of phase 3 IDEAL framework. | Eur J Surg Oncol | 2021 | https://conductscience.org/library/papers/34023169 | PubMed |
| 2 | 39887896 | Global comparison of research ethical review protocols: insights from an international research collaborative. | BJU Int | 2025 | https://conductscience.org/library/papers/39887896 | PubMed |
| 3 | 38917777 | Early and late post-procedural complications in different orthotopic neobladder surgical approaches: A systematic review. | Surg Oncol | 2024 | https://conductscience.org/library/papers/38917777 | PubMed |
| 4 | 31277775 | Delaying Radical Cystectomy After Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer is Associated with Adverse Survival Outcomes. | Eur Urol Oncol | 2019 | https://conductscience.org/library/papers/31277775 | PubMed |
| 5 | 38688207 | Honing the Hunt: A Comprehensive Review of Cell-free Tumor DNA to Predict Neoadjuvant Therapy Efficacy in Bladder Cancer. | Clin Genitourin Cancer | 2024 | https://conductscience.org/library/papers/38688207 | PubMed |
| 6 | 41707170 | Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer. | N Engl J Med | 2026 | https://conductscience.org/library/papers/41707170 | PubMed |
| 7 | 38673019 | Advances in Urinary Diversion: From Cutaneous Ureterostomy to Orthotopic Neobladder Reconstruction-A Comprehensive Review. | J Pers Med | 2024 | https://conductscience.org/library/papers/38673019 | PubMed |
| 8 | 27053504 | Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Systematic Review and Two-Step Meta-Analysis. | Oncologist | 2016 | https://conductscience.org/library/papers/27053504 | PubMed |
| 9 | 30268659 | Epidemiology of Bladder Cancer: A Systematic Review and Contemporary Update of Risk Factors in 2018. | Eur Urol | 2018 | https://conductscience.org/library/papers/30268659 | PubMed |
| 10 | 33201207 | Bladder Cancer: A Review. | JAMA | 2020 | https://conductscience.org/library/papers/33201207 | PubMed |
| 11 | 19142878 | Mortality increases when radical cystectomy is delayed more than 12 weeks: results from a Surveillance, Epidemiology, and End Results-Medicare analysis. | Cancer | 2009 | https://conductscience.org/library/papers/19142878 | PubMed |
| 12 | 40822997 | Neoadjuvant Immunotherapy in Bladder Cancer: Ushering in a New Era of Treatment-A Systematic Review of Current Evidence. | Eur Urol Open Sci | 2025 | https://conductscience.org/library/papers/40822997 | PubMed |
| 13 | 38572751 | Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. | CA Cancer J Clin | 2024 | https://conductscience.org/library/papers/38572751 | PubMed |
| 14 | 32891639 | Impact of Perioperative Multidisciplinary Rehabilitation Pathway on Early Outcomes after Robot-assisted Radical Cystectomy: A Matched Analysis. | Urology | 2021 | https://conductscience.org/library/papers/32891639 | PubMed |
| 15 | 32444265 | Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in the Detection of Clinically Significant Prostate Cancer in the Prostate Imaging Reporting and Data System Era: A Systematic Review and Meta-analysis. | Eur Urol | 2020 | https://conductscience.org/library/papers/32444265 | PubMed |
| 16 | 24887047 | The burden of bladder cancer care: direct and indirect costs. | Curr Opin Urol | 2014 | https://conductscience.org/library/papers/24887047 | PubMed |
| 17 | 24189391 | Guidelines for perioperative care after radical cystectomy for bladder cancer: Enhanced Recovery After Surgery (ERAS(®)) society recommendations. | Clin Nutr | 2013 | https://conductscience.org/library/papers/24189391 | PubMed |
| 18 | 32597214 | Comparing Perioperative Complications Between Laparoscopic and Robotic Radical Cystectomy for Bladder Cancer. | J Endourol | 2020 | https://conductscience.org/library/papers/32597214 | PubMed |
| 19 | 39846128 | Immunotherapy-based neoadjuvant treatment and complication rates after radical cystectomy. | BJU Int | 2025 | https://conductscience.org/library/papers/39846128 | PubMed |
| 20 | 38197902 | The effect of hospital caseload on perioperative mortality, morbidity and costs in bladder cancer patients undergoing radical cystectomy: results of the German nationwide inpatient data. | World J Urol | 2024 | https://conductscience.org/library/papers/38197902 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42226192
GET https://conductscience.org/api/papers/v1/42226192/references?page=2